Moderna begins late phase COVID-19 vaccine trials for children

ByABC7 News Staff KGO logo
Thursday, December 10, 2020
Moderna begins late phase COVID-19 vaccine trials for minors
The pharmaceuticals giant Moderna has begun late-stage testing of their coronavirus vaccine on minors. Roughly 3,000 children between the ages of 12 and 18 have been enrolled in the trial.

SAN FRANCISCO (KGO) -- On Thursday, the pharmaceutical giant Moderna announced it injected the first minors in their ongoing coronavirus vaccine trials.

WATCH: When and where? How COVID-19 vaccines will roll out in US

"Good Morning America" breaks down what we know about the future of the coronavirus vaccine.

The company says that participants in the test are between the ages of 12 years old to less than 18 years old, and they expect to enroll close to 3,000 participants in total.

This new testing is taking place during the second and third phases of the larger vaccine trial.

The vaccine being given to the children is the same vaccine being used on adults, Moderna says.

RELATED: Marin Co. public school teachers may get priority for COVID-19 vaccine

The U.S. Food and Drug Administration is scheduled to vote on emergency approval of Moderna's COVID-19 vaccine next Thursday.

If you have a question or comment about the coronavirus pandemic, submit yours via the form below or here.

Get the latest news, information and videos about the novel coronavirus pandemic here